ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Expected of Fund Cancer Education Grants In Fiscal 1986; Final Fate to Be Decided This Week

March 7, 1986

In Brief: NCI Authorization Should be $1.3 Billion, Humphrey Tells Kennedy; GOG Gets New Life

March 3, 1978

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

January 26, 2007

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

AACI’s “12 Tasks” Outlined to Board

March 28, 1975